Preferred Label : Buprenorphine, Naloxone Drug Combination;
MeSH definition : A pharmaceutical preparation that combines buprenorphine, an OPIOID ANALGESIC with
naloxone, a NARCOTIC ANTAGONIST to reduce the potential for NARCOTIC DEPENDENCE in
the treatment of pain. It may also be used for OPIATE SUBSTITUTION THERAPY.; A pharmaceutical preparation that combines buprenorphine, an OPIOID ANALGESICS with
naloxone, a NARCOTIC ANTAGONISTS to reduce the potential for NARCOTIC DEPENDENCE in
the treatment of pain. It may also be used for OPIOID SUBSTITUTION THERAPY.;
MeSH synonym : Buprenorphine-Naloxone Drug Combination; Combination, Buprenorphine-Naloxone Drug; Drug Combination, Buprenorphine-Naloxone; Buprenorphine-Naloxone; Buprenorphine Naloxone; Naloxone, Buprenorphine; Buprenorphine-Naloxone Combination; Buprenorphine Naloxone Combination; Combination, Buprenorphine-Naloxone; Buprenorphine Naloxone Drug Combination;
MeSH hyponym : suboxone;
Wikipedia link : https://en.wikipedia.org/wiki/Suboxone;
Is substance : O;
Origin ID : D000069479;
UMLS CUI : C1169989;
Allowable qualifiers
- CISMeF manual mappings
- Pharmacological action(s)
- Record concept(s)
- Semantic type(s)
- UMLS correspondences (same concept)
A pharmaceutical preparation that combines buprenorphine, an OPIOID ANALGESIC with
naloxone, a NARCOTIC ANTAGONIST to reduce the potential for NARCOTIC DEPENDENCE in
the treatment of pain. It may also be used for OPIATE SUBSTITUTION THERAPY.
A pharmaceutical preparation that combines buprenorphine, an OPIOID ANALGESICS with
naloxone, a NARCOTIC ANTAGONISTS to reduce the potential for NARCOTIC DEPENDENCE in
the treatment of pain. It may also be used for OPIOID SUBSTITUTION THERAPY.
https://ansm.sante.fr/tableau-marr/buprenorphine-naloxone
2022
false
false
false
France
French
guidelines for drug use
Buprenorphine, Naloxone Drug Combination
Buprenorphine, Naloxone Drug Combination
risk management
administration, sublingual
buprenorphine, combinations
patients guideline
opioid-related disorders
opiate substitution treatment
continuity of patient care
pregnancy
breast feeding
hepatic insufficiency
drug interactions
---
https://www.has-sante.fr/jcms/p_3280871/fr/zubsolv-buprenorphine/naloxone
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
Product containing only buprenorphine and naloxone in oromucosal dose form (medicinal
product form)
administration, sublingual
Buprenorphine, Naloxone Drug Combination
adult
adolescent
opiate substitution treatment
narcotic antagonists
opioid-related disorders
buprenorphine, combinations
evaluation of the transparency committee
---
https://pharmactuel.com/index.php/pharmactuel/article/view/1230
2019
false
false
false
false
Canada
Buprenorphine, Naloxone Drug Combination
comparative effectiveness research
naltrexone
treatment outcome
opioid-related disorders
Delayed-Action preparations
critical appraisal or critical reading
---
https://www.has-sante.fr/portail/jcms/c_2892927/fr/zubsolv
2019
false
false
false
France
French
Buprenorphine, Naloxone Drug Combination
Buprenorphine, Naloxone Drug Combination
treatment outcome
insurance, health, reimbursement
opioid-related disorders
adult
adolescent
evaluation of the transparency committee
buprenorphine, combinations
administration, sublingual
---
Zubsolv - buprenorphine / naloxone
https://www.ema.europa.eu/medicines/human/EPAR/Zubsolv
2018
false
United Kingdom
English
French
syndication feed
Buprenorphine, Naloxone Drug Combination
Buprenorphine, Naloxone Drug Combination
narcotic antagonists
narcotic antagonists
drug approval
europe
continuity of patient care
pregnancy
breast feeding
drug interactions
administration, sublingual
drug evaluation, preclinical
opioid-related disorders
treatment outcome
adult
adolescent
buprenorphine, combinations
opiate substitution treatment
drug evaluation
summary of product characteristics
package leaflet
---
http://www.cfp.ca/content/63/3/e153.full
2017
false
false
true
false
Canada
French
journal article
opioid-related disorders
methadone
analgesics, opioid
Buprenorphine, Naloxone Drug Combination
pregnancy
adolescent
aged
case reports
---
In Bulletin de l’Académie nationale de médecine
http://www.academie-medecine.fr/wp-content/uploads/2015/07/Communiqu%C3%A9-Bupr%C3%A9norphine-30-06-2015-Version-corrig%C3%A9e-du-30-6-151.pdf
2015
false
false
false
false
France
French
buprenorphine
prescription drug misuse
drug overdose
administration, oral
opiate substitution treatment
opioid-related disorders
guidelines for drug use
narcotics
injections, intravenous
narcotic antagonists
substance abuse, intravenous
drugs, generic
drug trafficking
buprenorphine
buprenorphine, combinations
Buprenorphine, Naloxone Drug Combination
Prescription Drug Overuse
---
http://www.has-sante.fr/portail/jcms/c_2030404/fr/suboxone
http://www.has-sante.fr/portail/jcms/c_666452/suboxone
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-07/suboxone_ct_5344.pdf
http://www.has-sante.fr/portail/jcms/c_2030404/fr/suboxone-buprenorphine/naloxone-traitement-de-la-dependance-aux-opioides
2015
false
France
French
English
guidelines for drug use
Buprenorphine Hydrochloride
Naloxone Hydrochloride Dihydride
Buprenorphine, Naloxone Drug Combination
buprenorphine, combinations
drug combinations
administration, sublingual
narcotic antagonists
opioid-related disorders
insurance, health, reimbursement
adult
adolescent
treatment outcome
opiate substitution treatment
evaluation of the transparency committee
---
http://www.meddispar.fr/Medicaments/SUBOXONE-2-B-7/(type)/name/(value)/SUBOXONE/(cip)/3400937761321
2012
false
France
French
Buprenorphine, Naloxone Drug Combination
narcotics
opiate substitution treatment
buprenorphine, combinations
drug prescriptions
legislation, drug
administration, sublingual
drug combinations
drug information
---
http://www.meddispar.fr/Medicaments/SUBOXONE-8-B-7/(type)/name/(value)/SUBOXONE/(cip)/3400937761550
2012
false
France
French
drug information
Buprenorphine, Naloxone Drug Combination
drug combinations
administration, sublingual
narcotics
legislation, drug
drug prescriptions
buprenorphine, combinations
opiate substitution treatment
---
https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/suboxone-1753.html
2012
false
Canada
English
French
Buprenorphine, Naloxone Drug Combination
evaluation of the transparency committee
narcotic antagonists
opiate substitution treatment
treatment outcome
Cost-Benefit analysis
administration, sublingual
drug combinations
opioid-related disorders
buprenorphine, combinations
drug evaluation
---
https://www.ema.europa.eu/medicines/human/EPAR/Suboxone
2010
false
United Kingdom
English
French
syndication feed
Buprenorphine, Naloxone Drug Combination
Buprenorphine, Naloxone Drug Combination
drug evaluation
opioid-related disorders
treatment outcome
adult
adolescent
buprenorphine, combinations
opiate substitution treatment
drug evaluation
summary of product characteristics
package leaflet
---
